Ross Breckenridge
Directeur Général chez Arjuna Therapeutics
Profil
Ross Breckenridge is currently the Chief Executive Officer & Director at Arjuna Therapeutics and Director at CdLS Foundation UK & Ireland.
He previously served as the President, Chief Executive Officer & Director at Silver Creek Pharmaceuticals, Inc. from 2015 to 2018.
He was also an Independent Director at REVA Medical, Inc. from 2015 to 2020.
Additionally, he served as a Director at Empower India Ltd.
Dr. Breckenridge holds a doctorate degree from both the University of Oxford and the University of Cambridge.
Postes actifs de Ross Breckenridge
| Sociétés | Poste | Début |
|---|---|---|
| CdLS Foundation UK & Ireland | Directeur/Membre du Conseil | - |
Arjuna Therapeutics
 Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | Directeur Général | - |
Anciens postes connus de Ross Breckenridge
| Sociétés | Poste | Fin |
|---|---|---|
| REVA MEDICAL INC | Directeur/Membre du Conseil | 01/01/2020 |
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Directeur Général | 01/09/2018 |
| EMPOWER INDIA LIMITED | Directeur/Membre du Conseil | - |
Formation de Ross Breckenridge
| University of Oxford | Doctorate Degree |
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EMPOWER INDIA LIMITED | Distribution Services |
| Entreprise privées | 4 |
|---|---|
REVA Medical, Inc.
 REVA Medical, Inc. Medical SpecialtiesHealth Technology REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA. | Health Technology |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
| CdLS Foundation UK & Ireland | Miscellaneous |
Arjuna Therapeutics
Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | Health Services |